tiprankstipranks
Trending News
More News >
Castle Biosciences (CSTL)
NASDAQ:CSTL
US Market

Castle Biosciences (CSTL) Ratios

Compare
450 Followers

Castle Biosciences Ratios

CSTL's free cash flow for Q3 2025 was $0.77. For the 2025 fiscal year, CSTL's free cash flow was decreased by $ and operating cash flow was
gt;-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
6.47 7.29 6.20 8.09 14.21
Quick Ratio
6.31 7.13 6.04 7.98 14.13
Cash Ratio
1.55 2.42 2.07 3.40 13.25
Solvency Ratio
0.34 0.45 -0.73 -1.17 -0.55
Operating Cash Flow Ratio
1.12 1.31 -0.12 -1.15 -0.76
Short-Term Operating Cash Flow Coverage
0.00 233.33 0.00 -23.44 -16.10
Net Current Asset Value
$ 261.83M$ 284.75M$ 233.56M$ 244.11M$ 302.91M
Leverage Ratios
Debt-to-Assets Ratio
0.07 0.05 0.03 0.03 0.02
Debt-to-Equity Ratio
0.08 0.06 0.04 0.03 0.02
Debt-to-Capital Ratio
0.07 0.05 0.04 0.03 0.02
Long-Term Debt-to-Capital Ratio
0.02 0.02 0.00 0.00 0.00
Financial Leverage Ratio
1.20 1.17 1.16 1.12 1.12
Debt Service Coverage Ratio
249.78 40.72 -4.10K -31.54 -23.63
Interest Coverage Ratio
-268.72 15.03 -6.18K -5.36K -40.08K
Debt to Market Cap
<0.01 0.01 0.00 <0.01 <0.01
Interest Debt Per Share
1.49 0.97 0.57 0.51 0.32
Net Debt to EBITDA
-1.88 -2.45 1.85 1.88 8.78
Profitability Margins
Gross Profit Margin
79.94%81.87%79.53%76.64%83.18%
EBIT Margin
-5.47%6.67%-26.10%-50.27%-42.53%
EBITDA Margin
7.51%11.48%-20.49%-42.57%-38.91%
Operating Profit Margin
-10.17%2.61%-30.93%-66.51%-42.60%
Pretax Profit Margin
-5.51%6.49%-26.10%-50.28%-42.53%
Net Profit Margin
-3.56%5.49%-26.15%-48.99%-33.26%
Continuous Operations Profit Margin
-3.56%5.49%-26.15%-48.99%-33.26%
Net Income Per EBT
64.69%84.61%100.18%97.44%78.21%
EBT Per EBIT
54.15%248.72%84.39%75.60%99.83%
Return on Assets (ROA)
-2.17%3.43%-12.68%-15.01%-6.76%
Return on Equity (ROE)
-2.69%4.00%-14.69%-16.82%-7.60%
Return on Capital Employed (ROCE)
-6.88%1.80%-16.76%-22.16%-9.16%
Return on Invested Capital (ROIC)
-4.44%1.52%-16.74%-21.41%-7.12%
Return on Tangible Assets
-2.65%4.29%-17.10%-20.92%-8.37%
Earnings Yield
-1.22%2.46%-9.94%-10.95%-2.90%
Efficiency Ratios
Receivables Turnover
6.94 6.48 5.74 5.84 5.44
Payables Turnover
5.64 8.72 4.38 6.77 6.21
Inventory Turnover
7.96 7.40 5.66 8.04 7.83
Fixed Asset Turnover
3.43 5.30 5.82 5.17 5.57
Asset Turnover
0.61 0.63 0.48 0.31 0.20
Working Capital Turnover Ratio
1.15 1.19 0.87 0.47 0.26
Cash Conversion Cycle
33.71 63.78 44.73 53.96 54.93
Days of Sales Outstanding
52.57 56.30 63.61 62.53 67.05
Days of Inventory Outstanding
45.83 49.32 64.44 45.38 46.62
Days of Payables Outstanding
64.69 41.84 83.32 53.95 58.73
Operating Cycle
98.40 105.62 128.05 107.91 113.67
Cash Flow Ratios
Operating Cash Flow Per Share
2.47 2.34 -0.21 -1.60 -0.76
Free Cash Flow Per Share
1.01 1.32 -0.72 -1.81 -0.89
CapEx Per Share
1.45 1.02 0.51 0.22 0.14
Free Cash Flow to Operating Cash Flow
0.41 0.56 3.42 1.14 1.18
Dividend Paid and CapEx Coverage Ratio
1.70 2.29 -0.41 -7.40 -5.45
Capital Expenditure Coverage Ratio
1.70 2.29 -0.41 -7.40 -5.45
Operating Cash Flow Coverage Ratio
1.66 2.46 -0.37 -3.13 -2.35
Operating Cash Flow to Sales Ratio
0.18 0.20 -0.03 -0.30 -0.20
Free Cash Flow Yield
2.17%4.94%-3.33%-7.71%-2.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-81.91 40.57 -10.06 -9.14 -34.44
Price-to-Sales (P/S) Ratio
3.40 2.23 2.63 4.48 11.45
Price-to-Book (P/B) Ratio
2.15 1.62 1.48 1.54 2.62
Price-to-Free Cash Flow (P/FCF) Ratio
46.02 20.26 -30.05 -12.97 -47.97
Price-to-Operating Cash Flow Ratio
16.22 11.41 -102.81 -14.72 -56.77
Price-to-Earnings Growth (PEG) Ratio
2.62 -0.31 0.59 -0.08 -0.27
Price-to-Fair Value
2.15 1.62 1.48 1.54 2.62
Enterprise Value Multiple
43.40 16.96 -10.99 -8.63 -20.65
Enterprise Value
1.12B 646.87M 494.88M 503.67M 756.07M
EV to EBITDA
43.40 16.96 -10.99 -8.63 -20.65
EV to Sales
3.26 1.95 2.25 3.68 8.04
EV to Free Cash Flow
44.11 17.70 -25.71 -10.65 -33.65
EV to Operating Cash Flow
18.12 9.97 -87.96 -12.09 -39.83
Tangible Book Value Per Share
14.58 12.59 10.22 10.47 12.84
Shareholders’ Equity Per Share
18.64 16.41 14.60 15.32 16.38
Tax and Other Ratios
Effective Tax Rate
0.35 0.15 >-0.01 0.03 0.22
Revenue Per Share
13.71 11.96 8.20 5.26 3.74
Net Income Per Share
-0.49 0.66 -2.14 -2.58 -1.24
Tax Burden
0.65 0.85 1.00 0.97 0.78
Interest Burden
1.01 0.97 1.00 1.00 1.00
Research & Development to Revenue
0.15 0.16 0.24 0.33 0.32
SG&A to Revenue
0.19 0.23 0.30 0.41 0.00
Stock-Based Compensation to Revenue
0.10 0.15 0.23 0.27 0.23
Income Quality
-5.05 3.56 0.10 0.62 0.61
Currency in USD